Vflow21

About

Funding history · 2 rounds · — total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Vflow21's primary focus in the medical device sector?

Vflow21 is a medical device company that develops innovative solutions for neurovascular diseases, specifically focusing on Idiopathic Intracranial Hypertension and Tinnitus Treatment.

When was Vflow21 founded?

Vflow21 was founded in July 2021.

Where is Vflow21 headquartered?

Vflow21 is headquartered in Tel Aviv-Yafo, Israel.

Which investors participated in Vflow21's Series A round in June 2023?

The Israel Innovation Authority invested in Vflow21's Series A round in June 2023.

Which investor led Vflow21's undisclosed funding round in April 2025?

Sanara Capital led Vflow21's undisclosed funding round in April 2025.

What is Vflow21's current funding stage?

Vflow21 is currently in the Series A funding stage.

How many employees does Vflow21 currently have?

Vflow21 currently has 7 employees.

Who are the founders of Vflow21?

The founders of Vflow21 are Anat Horev and Bilha Cahana.

What is the product stage of Vflow21?

Vflow21's product is currently in the R&D stage.

Sectors & technology

Tags